Latest Bad News About The Jabs

• A previously healthy 36-year-old mother of two died 11 days after receiving a Pfizer COVID-19 shot; her death was deemed to be caused by myocarditis due to the shot

• Emergency calls for cardiac arrest and acute coronary syndrome increased more than 25% among 16- to 39-year-olds from January to May 2021, compared to the same time period in 2019 and 2020

• Pfizer deliberately excluded pregnant women from COVID-19 shot trials; the recommendation that the shots are safe and effective for pregnant women was based on a 42-day study involving 44 rats

• Research conducted by the New York State Department of Health found the shots’ effectiveness declined rapidly among 5- to 11-year-olds, falling from 68% to just 12%

• Considering the adverse effects and lack of effectiveness, many have called for an immediate withdrawal of the shots

 

A previously healthy 36-year-old mother of two died 11 days after receiving a Pfizer COVID-19 shot; her death was deemed to be caused by myocarditis due to the shot.

Pfizer deliberately excluded pregnant women from COVID-19 shot trials; the recommendation that the shots are safe and effective for pregnant women was based on a 42-day study involving 44 rats.

The researchers evaluated the association between the volume of the calls and other factors, including COVID-19 shots and COVID-19 infection, but a link was only found for the shots:12.

Regarding the shots for pregnant women, Wolf said, in an interview with Stephen Bannon on "War Room," that a spike in severe adverse events among pregnant women coincides with the rollout of COVID-19 shots.

Clinical trials for COVID-19 shots did not collect data about menstrual cycles following injection, and the Vaccine Adverse Event Reporting System does not actively collect menstrual cycle information either, making it difficult to initially determine whether the shots were having an effect.

The lackluster response was blamed on the dosage discrepancies among the age groups, as 5- to 11-year-olds receive two 10-microgram Pfizer shots, while 12- to 17-year-olds receive 30-microgram shots.

The low effectiveness five months after the initial shot series is what prompted officials to recommend a booster dose - and the third shot "Boosted" effectiveness to 87%. This boost was short-lived, however.

https://www.thelibertybeacon.com/latest-bad-news-about-the-jabs/